According to a report presented at the American College of Rheumatologys annual meeting.

Breast cancer patients more likely to have joint pain from taking AIs: Study Breast cancer patients will have joint pain from taking aromatase inhibitors if they possess advanced stage tumor, according to a report presented at the American College of Rheumatology’s annual meeting, held Nov. 7-11, in Atlanta. The analysis is one of the first to recognize factors that raise the likelihood that a patient are affected joint pain from AI therapy . AIs, the typical adjuvant therapy for post-menopausal breast cancer, could cause joint pain in patients, mostly in the wrists and hands.

Breast cancer individuals treated with chemotherapy medication Taxol more likely to develop chronic neuropathic pain Breast cancer patients treated with the chemotherapy drug Taxol will develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Discomfort Society. Researchers from the University of Texas MD Anderson Cancer Center conducted a survey of breast cancer individuals who participated in clinical trials of Taxol from 1994 to 2001. There were 240 respondents.

Related Articles

Other Articles from "pediatrics":